The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
MicroRNAs and glioblastoma; the stem cell connection
Abstract
Recent data draw close parallels between cancer, including glial brain tumors, and the biology of stem and progenitor cells. At the same time, it has become clear that one of the major roles that microRNAs play is in the regulation of stem cell biology, differentiation, and cell 'identity'. For example, microRNAs have been increasingly implicated in the regulation of neural differentiation. Interestingly, initial studies in the incurable brain tumor glioblastoma multiforme strongly suggest that microRNAs involved in neural development play a role in this disease. This encourages the idea that certain miRs allow continued tumor growth through the suppression of differentiation and the maintenance of the stem cell-like properties of tumor cells. These concepts will be explored in this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR-128, miR-124, and miR-137 are all enriched in the brain and have been shown to regulate neuronal differentiation, maturation, and/or survival [15], [20]–[23].”
From Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene (2011) · cites this paper as [21]
In the citing paper
“It is hypothesized that glioblastomas, like other cancers such as leukemia [51], arise and are maintained by a population of progenitor cells with stem-like characteristics including the ability to self-renew for unlimited proliferation [21], [52], [53].”
From Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene (2011) · cites this paper as [21]
In the citing paper
“Additionally, miR-128 is highly enriched in the brain as it is expressed by neurons and is induced during neuronal differentiation of embryonal carcinoma (EC) cells [20], [21], thus making it an ideal candidate to limit cell suicide gene expression.”
From Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene (2011) · cites this paper as [21]
Citations
Cites
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578
Regulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · cited 1×
“Downregulation of miR-21 in glioblastoma cells caused de-repression of these pathways, causing repression of growth, increased apoptosis, and cell-cycle arrest.(70) Several well-known glioma tumor-suppressor genes”
Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2390-08.2008 · Cited by 679
MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision
Johnston, R. J., Chang, S., Etchberger, J. F., Ortiz, C. O., & Hobert, O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505530102 · Cited by 276
Flagged first, then by citations
Research works printed but not linked: 70
- Davis FG, McCarthy BJ . Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 2001; 1: 395–401. · DOI
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996. · DOI · Paper page
- Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21: 2683–2710. · DOI · Paper page
- Dell'Albani P . Stem cell markers in gliomas. Neurochem Res 2008; 33: 2407–2415. · DOI
- Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257–2261. · DOI · Paper page
- Esquela-Kerscher A, Slack FJ . Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269. · DOI
- Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233. · DOI · Paper page
- Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005; 334: 1351–1358. · DOI · Paper page
- Chan JA, Krichevsky AM, Kosik KS . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029–6033. · DOI · Paper page
- Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008; 68: 9125–9130. · DOI · Paper page
- Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14–22. · DOI · Paper page
- Huntly BJP, Gilliland DG . Leukemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 2005; 5: 311–321. · DOI · Paper page
- Stingl J, Caldas C . Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007; 445: 111–115.
- Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396–401. · DOI
- Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756–760. · DOI
- Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 7843–7848. · DOI
- Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ et al. CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 4010–4015. · DOI
- Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ . Efficient tumor formation by single human melanoma cells. Nature 2008; 456: 593–598. · DOI
- Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster Jr JR et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS ONE 2008; 3: e3655. · DOI
- Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391–403. · DOI
- Stiles CD, Rowitch DH . Glioma stem cells: a midterm exam. Neuron 2008; 58: 832–846. · DOI
- Wienholds E, Plasterk RH . MicroRNA function in animal development. FEBS Lett 2005; 579: 5911–5922. · DOI
- Lee RC, Feinbaum RL, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843–854. · DOI · Paper page
- Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403: 901–906. · DOI
- Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005; 438: 671–674. · DOI
- Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228–233. · DOI
- Chen CZ, Li L, Lodish HF, Bartel DP . MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86. · DOI · Paper page
- Hatfield S, Ruohola-Baker H . MicroRNA and stem cell function. Cell Tissue Res 2008; 331: 57–66. · DOI
- Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ . Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 2005; 102: 12135–12140. · DOI · Paper page
- Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215–217. · DOI · Paper page
- Houbaviy HB, Murray MF, Sharp PA . Embryonic stem cell-specific microRNAs. Dev Cell 2003; 5: 351–358. · DOI
- Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I . MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455: 1124–1128. · DOI
- Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM . Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm Genome 2007; 18: 316–327. · DOI
- Papagiannakopoulos T, Kosik KS . MicroRNAs: regulators of oncogenesis and stemness. BMC Med 2008; 6: 15–18. · DOI
- Christensen M, Schratt GM . MicroRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci Lett 2009; in press PMID:19393715. · DOI
- Gao FB . Posttranscriptional control of neuronal development by microRNA networks. Trends Neurosci 2008; 31: 20–26. · DOI
- Kim J, Krichevsky A, Grad Y, Hayes GD, Kosik KS, Church GM et al. Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development. Proc Natl Acad Sci USA 2005; 102: 18017–18022. · DOI
- Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005; 308: 833–838. · DOI · Paper page
- Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317: 1220–1224. · DOI · Paper page
- Schaefer A, O'Carroll D, Tan L, Hillman D, Sugimori M, Llinas R et al. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007; 204: 1553–1558. · DOI · Paper page
- De Pietri Tonelli D, Pulvers JN, Haffner C, Murchison EP, Hannon GJ, Huttner WB . miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 2008; 135: 3911–3921. · DOI · Paper page
- Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H . Stem cell division is regulated by the microRNA pathway. Nature 2005; 435: 974–978. · DOI
- Gangaraju VK, Lin H . MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009; 10: 116–125. · DOI
- Shi Y, Sun G, Zhao C, Stewart R . Neural stem cell self-renewal. Crit Rev Oncol Hematol 2008; 65: 43–53. · DOI
- Krichevsky AM, Sonntag KC, Isacson O, Kosik KS . Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 2006; 24: 857–864. · DOI · Paper page
- Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008; 134: 521–533. · DOI
- Canoll P, Goldman JE . The interface between glial progenitors and gliomas. Acta Neuropathol 2008; 116: 465–477. · DOI
- Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS et al. MicroRNA profiling in human medulloblastoma. Int J Cancer 2009; 124: 568–577. · DOI
- Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 2009; 4: e4998. · DOI
- Conaco C, Otto S, Han JJ, Mandel G . Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 2006; 103: 2422–2427. · DOI · Paper page
- Wu J, Xie X . Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 2006; 7: R85. · DOI · Paper page
- Makeyev EV, Zhang J, Carrasco MA, Maniatis T . The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007; 27: 435–448. · DOI · Paper page
- Visvanathan J, Lee S, Lee B, Lee JW, Lee SK . The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev 2007; 21: 744–749. · DOI · Paper page
- Yeo M, Lee SK, Lee B, Ruiz EC, Pfaff SL, Gill GN . Small CTD phosphatases function in silencing neuronal gene expression. Science 2005; 307: 596–600. · DOI · Paper page
- Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ . Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962–967. · DOI
- Sparmann A, van Lohuizen M . Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6: 846–856. · DOI
- Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007; 12: 328–334. · DOI
- Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X et al. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 2009; 87: 43–51. · DOI · Paper page
- Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695–1699. · DOI
- Stark A, Brennecke J, Russell RB, Cohen SM . Identification of drosophila MicroRNA targets. PLoS Biol 2003; 1: E60. · DOI
- Li X, Carthew RW . A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 2005; 123: 1267–1277. · DOI · Paper page
- Tsang J, Zhu J, van Oudenaarden A . MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 2007; 26: 753–767. · DOI · Paper page
- Li X, Cassidy JJ, Reinke CA, Fischboeck S, Carthew RW . A microRNA imparts robustness against environmental fluctuation during development. Cell 2009; 137: 273–282. · DOI · Paper page
- Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68: 3566–3572. · DOI · Paper page
- Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K . MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007; 67: 8994–9000. · DOI · Paper page
- Krichevsky AM, Gabriely G . miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13: 39–53. · DOI · Paper page
- Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S . REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 2008; 453: 223–227. · DOI
- Jørgensen HF, Terry A, Beretta C, Pereira CF, Leleu M, Chen ZF et al. REST selectively represses a subset of RE1-containing neuronal genes in mouse embryonic stem cells. Development 2009; 136: 715–721. · DOI · Paper page
- Shibata M, Kurokawa D, Nakao H, Ohmura T, Aizawa S . MicroRNA-9 modulates Cajal-Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium. J Neurosci 2008; 28: 10415–10421. · DOI · Paper page
- Nass D, Rosenwald S, Meiri E, Gilad S, Tabiban-Keissar H, Schlosberg A et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 2008; in press PMID:18624795. · DOI
Cited by
Sorted by citations
An updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
Adlakha, Y. K., & Saini, N. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-33 · Cited by 213
Skalsky, R. L., & Cullen, B. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024248 · Cited by 170
Metadata
- Authors
- Godlewski, J., Newton, H. B., Chiocca, E. A., & Lawler, S. E.
- Venue
- Cell Death & Differentiation
- Published
- 2009-06-12
- Volume
- 17
- Issue
- 2
- Pages
- 221-228
- ISSN
- 1350-9047
- 1476-5403
- Cited by
- 86
- References
- 6
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review